Oncodaily | Oncology News, Insights, Stories –
Oncodaily – Oncology News, Insights, Stories
Related Articles
Low-Grade Inflammation in Long COVID Syndrome Sustains a Persistent Platelet Activation Associated With Lung Impairment:
Highlights •Long COVID patients, compared to COVID-recovered asymptomatic subjects, present a platelet activation phenotype characterized mainly by a high number of circulating platelet-leukocyte a…
2025 Cancer Statistics Report: Lung Cancer Remains Leading Cause of Cancer Mortality in US | Docwire News
Although lung cancer incidence is declining and five-year survival rates are increasing, lung cancer remains the top cause of cancer mortality in the United States.
Episode 409: Everything You Need to Know About Heart Calcium and CT Imaging
Podcast Episode · Heart Doc VIP with Dr. Joel Kahn · 01/28/2025 · 29m
Is SVR linked to survival benefit in pacritinib-treated patients with myelofibrosis?
A study found that “pacritinib may offer a unique survival advantage” for patients with myelofibrosis (MF) and thrombocytopenia who achieve any spleen volume reduction (SVR).…
Managing Methotrexate Toxicity in Patients With CNS Lymphoma | Blood Cancers Today
The panel, moderated by Grzegorz Nowakowski, MD, discussed how to manage methotrexate toxicity in patients with CNS lymphoma.
When it comes to heart and brain health, these are numbers you should know
The American Heart Association has released its 2025 statistics update for heart disease and stroke, which spells out the scope of the problem, as well…
A New Year’s Wish for Nurses | Cancer Nursing Today
Theresa Brown, RN, explains her wish for nurses in this new year is that you find some way to acknowledge what COVID did to you,…
FDA Approves Ozempic for Kidney Disease | Docwire News
Based on FLOW trial results, the FDA has approved Ozempic (semaglutide) to treat chronic kidney disease (CKD) in adults with type 2 diabetes.
Newly FDA-approved Treatment Enhances Survival for Children and Adults with 2 Blood Cancer Types | Leukemia and Lymphoma Society
Newly FDA-approved Treatment Enhances Survival for Children and Adults with 2 Blood Cancer Types > Page Components
Andreas Charalambous: Highlighting the importance of national cancer plans with ELLOK – OncoDaily
Andreas Charalambous: Highlighting the importance of national cancer plans with ELLOK / Andreas Charalambous, cancer, ELLOC, European Cancer Organisation,
